<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02432196</url>
  </required_header>
  <id_info>
    <org_study_id>HMFIM -1000-PL</org_study_id>
    <nct_id>NCT02432196</nct_id>
  </id_info>
  <brief_title>Safety and Early Feasibility Study of the Harpoon Medical Device</brief_title>
  <acronym>EFS</acronym>
  <official_title>First In Man - Clinical Validation of the TSD-5</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harpoon Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Harpoon Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Prospective, Single Arm, Single Group Assignment, EU study to demonstrate the
      feasibility and safety of the Harpoon Medical TSD-5 in subjects with degenerative MR
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pairs of ePTFE suture will be placed in the posterior leaflet of the mitral valve using the
      Harpoon Medical TSD-5 in order to establish effective coaptation of the mitral leaflets
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 2015</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>30 days</time_frame>
    <description>Placement of at least one ePTFE chordae tendineae using the TSD-5 AND a reduction in mitral regurgitation &lt;= 2+ at the time of procedure AND at 30 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedural Safety</measure>
    <time_frame>30 days</time_frame>
    <description>Safety as assessed by Serious Adverse Events</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Mitral Valve Regurgitation</condition>
  <condition>Mitral Valve Prolapse</condition>
  <condition>Mitral Valve Insufficiency</condition>
  <arm_group>
    <arm_group_label>Mitral Valve Repair</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implanting ePTFE sutures as artificial chordae tendineae using the TSD-5</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mitral Valve Repair</intervention_name>
    <description>Harpoon Medical TSD-5</description>
    <arm_group_label>Mitral Valve Repair</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  All subjects referred for mitral valve surgery

          -  Presence of moderate to severe or severe mitral regurgitation as read on an
             echocardiographic study performed within 6 months prior to procedure.

          -  Able to sign informed consent

          -  Presence of isolated posterior leaflet mitral valve prolapse

          -  Subject is willing to return for follow-up and is capable of participating in all
             testing associated with this clinical investigation

        Exclusion Criteria:

          -  &lt; 18 years of age

          -  Infective endocarditis

          -  Severe Tricuspid regurgitation

          -  Anterior or bileaflet prolapse

          -  Functional mitral regurgitation

          -  Radiation or inflammatory (rheumatic) valve disease

          -  Requirement for concomitant cardiac surgery (e.g. coronary artery bypass grafting
             (CABG), aortic valve surgery, etc.)

          -  Cardiogenic shock at the time of enrollment

          -  ST segment elevation myocardial infarction requiring intervention within 7 days prior
             to enrollment

          -  Evidence of cirrhosis or hepatic synthetic failure

          -  Pregnancy at the time of enrollment

          -  Severe pulmonary hypertension (PA systolic pressure &gt; 60 mmHg)

          -  Previous cardiac surgery, or surgery on the left thoracic cavity or the cardiac apex

          -  Left ventricular, atrial or appendage thrombus

          -  Severely calcified mitral annulus

          -  Recent stroke (in the prior six months)

          -  STS risk score (for mitral valve repair) &gt; 6 percent

          -  Subjects with contraindications to transesophageal echocardiography

          -  Severe left ventricular dysfunction (EF &lt; 40 %)

          -  Excessively thin mitral leaflets

          -  Renal insufficiency (CKD stage 3 or above GFR &lt; 60)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Krzysztof Bartus, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jagiellonian University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jagiellonian University</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Cardiology</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2015</study_first_submitted>
  <study_first_submitted_qc>April 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2015</study_first_posted>
  <last_update_submitted>August 8, 2017</last_update_submitted>
  <last_update_submitted_qc>August 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mitral Valve Repair</keyword>
  <keyword>Transapical</keyword>
  <keyword>artificial chordae</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
    <mesh_term>Mitral Valve Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

